Raúl Cuauhtémoc Baptista Rosas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Raúl Cuauhtémoc Baptista Rosas has a total of 210 co-authors. Here are the top co-authors by number of shared publications:
- María Guadalupe Sánchez-Parada
Departamento de Ciencias Biomédicas, División de Ciencias de la Salud, Centro Universitario de Tonalá, Universidad de Guadalajara, Tonalá 45425, Jalisco, Mexico
11 shared publications - Arieh Roldán Mercado-Sesma
Departamento de Ciencias de la Salud-Enfermedad como Proceso Individual, Centro Universitario de Tonalá, Universidad de Guadalajara, Tonalá 45425, Mexico
10 shared publications - Ana Elizabeth González-Santiago
Departamento de Ciencias Biomédicas, División de Ciencias de la Salud, Centro Universitario de Tonalá, Universidad de Guadalajara, Tonalá 45425, Jalisco, Mexico
9 shared publications - Felipe de Jesús Orozco-Luna
Universidad de Guadalajara
8 shared publications - Laura Yareni Zuñiga
Departamento de Ciencias de la Salud-Enfermedad como Proceso Individual, Centro Universitario de Tonalá, Universidad de Guadalajara, Tonalá 45425, Mexico
8 shared publications - Luis Daniel Hernández-Ortega
Centro de Investigación Multidisciplinario en Salud, Centro Universitario de Tonalá, Universidad de Guadalajara, Av. Nuevo Periférico 555, Tonalá 45425, Jalisco, Mexico
7 shared publications
Latest Publications
- Open Access
- 18 August 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (16) , 7977
Folic Acid Supplementation and Risk of Gestational Diabetes Mellitus: A Systematic Review of the Literature
Gestational diabetes mellitus (GDM) affects approximately 14% of pregnancies globally and has been hypothesized to be influenced by periconceptional and early pregnancy folic acid (FA) supplementation, a practice recommended to prevent neural tube defects. To evaluate this association, we conducted a systematic review of studies published between 2015 and 2024 examining FA use and GDM risk. Twelve studies met the inclusion criteria, including ten cohort studies and two case-control studies. While findings were mixed, several prospective studies suggested that high daily FA intake (≥800 μg) or prolonged use (>3–6 months) may be associated with increased odds of GDM, especially when initiated preconceptionally. Conversely, standard-dose supplementation (≈400 μg) appeared neutral or potentially protective in some populations. Notably, high folate status combined with low vitamin B12 was linked to increased GDM risk, suggesting metabolic interaction. Overall, most studies were of moderate to high methodological quality. Although current evidence is inconclusive, these results support cautious use of high-dose FA supplementation and the importance of individualized prenatal nutrition, particularly considering B12 status. Further research is needed to clarify biological mechanisms.
- 18 August 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (16) , 7977
Open AccessFolic Acid Supplementation and Risk of Gestational Diabetes Mellitus: A Systematic Review of the Literature
Gestational diabetes mellitus (GDM) affects approximately 14% of pregnancies globally and has been hypothesized to be influenced by periconceptional and early pregnancy folic acid (FA) supplementation, a practice recommended to prevent neural tube defects. To evaluate this association, we conducted a systematic review of studies published between 2015 and 2024 examining FA use and GDM risk. Twelve studies met the inclusion criteria, including ten cohort studies and two case-control studies. While findings were mixed, several prospective studies suggested that high daily FA intake (≥800 μg) or prolonged use (>3–6 months) may be associated with increased odds of GDM, especially when initiated preconceptionally. Conversely, standard-dose supplementation (≈400 μg) appeared neutral or potentially protective in some populations. Notably, high folate status combined with low vitamin B12 was linked to increased GDM risk, suggesting metabolic interaction. Overall, most studies were of moderate to high methodological quality. Although current evidence is inconclusive, these results support cautious use of high-dose FA supplementation and the importance of individualized prenatal nutrition, particularly considering B12 status. Further research is needed to clarify biological mechanisms.
- Open Access
- 10 July 2025
- Published by Universidad de Guadalajara in Estudios Interdisciplinares de Economía, Empresa y Gobierno
- No. 4,p. 31-39
Quimioremediación de metales pesados en agua mediante síntesis de polímeros basados en química click
En este trabajo se propone el desarrollo de modelos de quimiorremediación in silico para la eliminación de metales pesados en agua, por medio de la síntesis de polímeros basados en química click. Se utilizan simulaciones computacionales en lenguaje R, se modelaron polímeros con ligandos específicos capaces de capturar iones metálicos, los cuales serán validados experimentalmente mediante espectrofotometría UV-Vis. La combinación de química click y modelado computacional permite optimizar procesos de remediación, reducir costos y riesgos, así como diseñar soluciones sostenibles y escalables adaptadas a distintos entornos contaminados. Esta estrategia contribuye a mejorar la calidad del agua y proteger el medio ambiente.
- 10 July 2025
- Published by Universidad de Guadalajara in Estudios Interdisciplinares de Economía, Empresa y Gobierno
- No. 4,p. 31-39
Open AccessQuimioremediación de metales pesados en agua mediante síntesis de polímeros basados en química click
En este trabajo se propone el desarrollo de modelos de quimiorremediación in silico para la eliminación de metales pesados en agua, por medio de la síntesis de polímeros basados en química click. Se utilizan simulaciones computacionales en lenguaje R, se modelaron polímeros con ligandos específicos capaces de capturar iones metálicos, los cuales serán validados experimentalmente mediante espectrofotometría UV-Vis. La combinación de química click y modelado computacional permite optimizar procesos de remediación, reducir costos y riesgos, así como diseñar soluciones sostenibles y escalables adaptadas a distintos entornos contaminados. Esta estrategia contribuye a mejorar la calidad del agua y proteger el medio ambiente.
- Open Access
- 19 June 2025
- Published by Instituto Mexicano del Seguro Social in Gaceta Médica de México
- Vol. 161 (1) , 108-115
Single nucleotide variants of the SLC2A2 gene in Mexican-origin population
Background: Diabetes, which is caused by environmental and genetic factors, has a high global prevalence (10.5%). Some single nucleotide variants (SNVs) modi...
- 19 June 2025
- Published by Instituto Mexicano del Seguro Social in Gaceta Médica de México
- Vol. 161 (1) , 108-115
Open AccessSingle nucleotide variants of the SLC2A2 gene in Mexican-origin population
Background: Diabetes, which is caused by environmental and genetic factors, has a high global prevalence (10.5%). Some single nucleotide variants (SNVs) modi...
- Open Access
- 1 April 2025
- Published by Instituto Mexicano del Seguro Social in Gaceta Médica de México
- Vol. 161 (1) , 108-115
Variantes de un solo nucleótido del gen SLC2A2 en población de origen mexicano
Antecedentes: La diabetes, causada por factores ambientales y genéticos, tiene alta prevalencia mundial (10.5 %). Algunas variantes de un solo nucleótido (SNV) modifican la función de glucotransportadores como GLUT2, que tiene un papel importante en la secreción de insulina y el metabolismo de la glucosa. Objetivo: Analizar las SNV asociadas a diabetes tipo 2 (DT2) en población mexicana. Material y métodos: Se utilizaron bases de datos de referencia para las SNV registradas para SLC2A2 asociadas a DT2 en población mexicana. Resultados: Se analizaron 83 SNV, entre las cuales se identificaron tres relevantes en población mexicana asociadas a DT2: rs5404, rs5406 y rs5398; la última es una variante patogénica (RM >1.0 y p < 0.05). Conclusiones: Es necesario un análisis y mapeo genético detallado junto con estudios de función para identificar el mecanismo por el cual las variantes de GLUT2 influyen en el desarrollo de diabetes.
- 1 April 2025
- Published by Instituto Mexicano del Seguro Social in Gaceta Médica de México
- Vol. 161 (1) , 108-115
Open AccessVariantes de un solo nucleótido del gen SLC2A2 en población de origen mexicano
Antecedentes: La diabetes, causada por factores ambientales y genéticos, tiene alta prevalencia mundial (10.5 %). Algunas variantes de un solo nucleótido (SNV) modifican la función de glucotransportadores como GLUT2, que tiene un papel importante en la secreción de insulina y el metabolismo de la glucosa. Objetivo: Analizar las SNV asociadas a diabetes tipo 2 (DT2) en población mexicana. Material y métodos: Se utilizaron bases de datos de referencia para las SNV registradas para SLC2A2 asociadas a DT2 en población mexicana. Resultados: Se analizaron 83 SNV, entre las cuales se identificaron tres relevantes en población mexicana asociadas a DT2: rs5404, rs5406 y rs5398; la última es una variante patogénica (RM >1.0 y p < 0.05). Conclusiones: Es necesario un análisis y mapeo genético detallado junto con estudios de función para identificar el mecanismo por el cual las variantes de GLUT2 influyen en el desarrollo de diabetes.
- Open Access
Prospects in the Use of Cannabis sativa Extracts in Nanoemulsions
Cannabis sativa plants have been widely investigated for their specific compounds with medicinal properties. These bioactive compounds exert preventive and curative effects on non-communicable and infectious diseases. However, C. sativa extracts have barely been investigated, although they constitute an affordable option to treat human diseases. Nonetheless, antioxidant, antimicrobial, and immunogenicity effects have been associated with C. sativa extracts. Furthermore, innovative extraction methods in combination with nanoformulations have been proposed to increase desirable compounds’ availability, distribution, and conservation, which can be aided by modern computational tools in a transdisciplinary approach. This review aims to describe available extraction and nanoformulation methods for C. sativa, as well as its known antioxidant, antimicrobial, and immunogenic activities. Critical points on the use of C. sativa extracts in nanoformulations are identified and some prospects are envisaged.
Open AccessProspects in the Use of Cannabis sativa Extracts in Nanoemulsions
Cannabis sativa plants have been widely investigated for their specific compounds with medicinal properties. These bioactive compounds exert preventive and curative effects on non-communicable and infectious diseases. However, C. sativa extracts have barely been investigated, although they constitute an affordable option to treat human diseases. Nonetheless, antioxidant, antimicrobial, and immunogenicity effects have been associated with C. sativa extracts. Furthermore, innovative extraction methods in combination with nanoformulations have been proposed to increase desirable compounds’ availability, distribution, and conservation, which can be aided by modern computational tools in a transdisciplinary approach. This review aims to describe available extraction and nanoformulation methods for C. sativa, as well as its known antioxidant, antimicrobial, and immunogenic activities. Critical points on the use of C. sativa extracts in nanoformulations are identified and some prospects are envisaged.
- Open Access
- 3 October 2024
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Novel risk loci for COVID-19 hospitalization among admixed American populations
The genetic basis of severe COVID-19 has been thoroughly studied, and many genetic risk factors shared between populations have been identified. However, reduced sample sizes from non-European groups have limited the discovery of population-specific common risk loci. In this second study nested in the SCOURGE consortium, we conducted a genome-wide association study (GWAS) for COVID-19 hospitalization in admixed Americans, comprising a total of 4702 hospitalized cases recruited by SCOURGE and seven other participating studies in the COVID-19 Host Genetic Initiative. We identified four genome-wide significant associations, two of which constitute novel loci and were first discovered in Latin American populations (BAZ2B and DDIAS). A trans-ethnic meta-analysis revealed another novel cross-population risk locus in CREBBP. Finally, we assessed the performance of a cross-ancestry polygenic risk score in the SCOURGE admixed American cohort. This study constitutes the largest GWAS for COVID-19 hospitalization in admixed Latin Americans conducted to date. This allowed to reveal novel risk loci and emphasize the need of considering the diversity of populations in genomic research.
- 3 October 2024
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Open AccessNovel risk loci for COVID-19 hospitalization among admixed American populations
The genetic basis of severe COVID-19 has been thoroughly studied, and many genetic risk factors shared between populations have been identified. However, reduced sample sizes from non-European groups have limited the discovery of population-specific common risk loci. In this second study nested in the SCOURGE consortium, we conducted a genome-wide association study (GWAS) for COVID-19 hospitalization in admixed Americans, comprising a total of 4702 hospitalized cases recruited by SCOURGE and seven other participating studies in the COVID-19 Host Genetic Initiative. We identified four genome-wide significant associations, two of which constitute novel loci and were first discovered in Latin American populations (BAZ2B and DDIAS). A trans-ethnic meta-analysis revealed another novel cross-population risk locus in CREBBP. Finally, we assessed the performance of a cross-ancestry polygenic risk score in the SCOURGE admixed American cohort. This study constitutes the largest GWAS for COVID-19 hospitalization in admixed Latin Americans conducted to date. This allowed to reveal novel risk loci and emphasize the need of considering the diversity of populations in genomic research.
- Open Access
- 30 July 2024
- Published by MDPI AG in Preprints.org
Using Association Rules to Explore Occult Patterns in Breast Cancer Mitochondrial Genomes
Single nucleotide polymorphisms in the mitochondrial genome have been investigated in relation to breast cancer. Certain variants could be associated with an increased risk of this malignant disease. These associations underline the importance of mitochondrial function in cancer biology and highlight the potential for mtDNA-based biomarkers and future therapies. The general objective of this research was to develop a model which is capable of identifying nonlinear patterns in breast cancer mitochondrial sequences. Association rules were used to explore mtDNA variant positions. The analysis included 41 breast cancer patients and 28 control samples. An a priori algorithm identified significant association rules with lift > 1 and confidence > 0.5. A total of 5562 rules for cancer and 157,140 for control sequences were refined after redundancy removal. A total of 150 associations were identified, of which only 78 showed significant support and confidence, while 315 and 1438 positions showed strong associations with breast cancer. Association rules analysis revealed significant patterns, especially in sequences associated with the control region and a specific locus around genes coding for tRNAs and NADH dehydrogenase subunits. However, further research is necessary to establish causality, clinical relevance, and to confirm these findings.
- 30 July 2024
- Published by MDPI AG in Preprints.org
Open AccessUsing Association Rules to Explore Occult Patterns in Breast Cancer Mitochondrial Genomes
Single nucleotide polymorphisms in the mitochondrial genome have been investigated in relation to breast cancer. Certain variants could be associated with an increased risk of this malignant disease. These associations underline the importance of mitochondrial function in cancer biology and highlight the potential for mtDNA-based biomarkers and future therapies. The general objective of this research was to develop a model which is capable of identifying nonlinear patterns in breast cancer mitochondrial sequences. Association rules were used to explore mtDNA variant positions. The analysis included 41 breast cancer patients and 28 control samples. An a priori algorithm identified significant association rules with lift > 1 and confidence > 0.5. A total of 5562 rules for cancer and 157,140 for control sequences were refined after redundancy removal. A total of 150 associations were identified, of which only 78 showed significant support and confidence, while 315 and 1438 positions showed strong associations with breast cancer. Association rules analysis revealed significant patterns, especially in sequences associated with the control region and a specific locus around genes coding for tRNAs and NADH dehydrogenase subunits. However, further research is necessary to establish causality, clinical relevance, and to confirm these findings.
- Open Access
- 2 February 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (2) , 352
Amelioration of Cytogenotoxic Damage in Drug Abusers Supplemented with Folic Acid
Background: Cytogenotoxic damage caused by the consumption of legal and illegal drugs in drug abusers has been demonstrated, primarily due to alterations in their antioxidant capacity, cellular repair mechanisms, and increased production of free radicals. Folic acid shows antioxidant activity by acting as a reducing agent, neutralizing present free radicals, and reducing genomic damage. Methods: The intervention involved administering 15 mg of folic acid, divided into three doses per day, to a group of 44 drug abusers. The frequency of nuclear abnormalities (NAs) was determined; micronuclei (MNs), nuclear buds (NBUDs), binucleated cells (BNs), abnormally condensed chromatin (CC), karyorrhexis (KX), pyknotic nuclei (PNs), and karyolysis (KL) were determined at different pre-treatment (baseline) and post-treatment time points at 15 and 30 days. Additionally, a group of 44 healthy individuals was used as the control group. Results: We observed a statistically significant decrease in the frequency of NAs in the drug abuser group (28.45 ± 17.74 before supplementation vs. 11.18 ± 7.42 at 15 days and 9.11 ± 10.9 at 30 days of supplementation). Specifically, it decreased the frequency of NBUDs, BNs, CC, KX, and PNs (p < 0.05). Conclusion: Our study demonstrates a clear improvement in cytogenotoxic damage in drug abusers supplemented with folic acid.
- 2 February 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (2) , 352
Open AccessAmelioration of Cytogenotoxic Damage in Drug Abusers Supplemented with Folic Acid
Background: Cytogenotoxic damage caused by the consumption of legal and illegal drugs in drug abusers has been demonstrated, primarily due to alterations in their antioxidant capacity, cellular repair mechanisms, and increased production of free radicals. Folic acid shows antioxidant activity by acting as a reducing agent, neutralizing present free radicals, and reducing genomic damage. Methods: The intervention involved administering 15 mg of folic acid, divided into three doses per day, to a group of 44 drug abusers. The frequency of nuclear abnormalities (NAs) was determined; micronuclei (MNs), nuclear buds (NBUDs), binucleated cells (BNs), abnormally condensed chromatin (CC), karyorrhexis (KX), pyknotic nuclei (PNs), and karyolysis (KL) were determined at different pre-treatment (baseline) and post-treatment time points at 15 and 30 days. Additionally, a group of 44 healthy individuals was used as the control group. Results: We observed a statistically significant decrease in the frequency of NAs in the drug abuser group (28.45 ± 17.74 before supplementation vs. 11.18 ± 7.42 at 15 days and 9.11 ± 10.9 at 30 days of supplementation). Specifically, it decreased the frequency of NBUDs, BNs, CC, KX, and PNs (p < 0.05). Conclusion: Our study demonstrates a clear improvement in cytogenotoxic damage in drug abusers supplemented with folic acid.
- 1 January 2024
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 65 (1-2) , 84-95
Cytogenotoxicity effects in addicts with multidrug consumption
Drug abuse is considered a global health problem with serious social impact. In recent decades, changes in drug consumption patterns have shown a clear rising trend in the use of multiple drugs. Although the buccal micronucleus cytome (BMCyt) assay has evaluated cytotoxicity in drug abuse, there has not been an approach that takes into account this pattern of multiple drug use. Therefore, in this study, we evaluate for the first time the cytogenotoxic effects in multidrug users, and its correlation with the amount consumed and years of abuse. This study was conducted on 166 individuals by the BMCyt assay. A total of 83 individuals with a history of multiple licit (alcohol and tobacco) and at least one illicit drug abuse (marijuana, methamphetamines, cocaine, and/or inhalants), and 83 healthy individuals, non‐drug abusers were analyzed. The results showed that drug abusers had higher frequencies of nuclear abnormalities nuclear buds, binucleated cells, pyknotic nuclei (PNs), karyorrhexis (KX), and abnormally condensed chromatin when compared with healthy controls. Moreover, results suggests that the use of licit and illicit drugs is related to cytogenotoxic damage, as was shown by an upward trend in the frequency of nuclear abnormalities identified in groups 1 (alcohol + tobacco + at least one illicit drug) and 2 (tobacco + at least one illicit drug). Furthermore, a positive correlation was found in the different groups, between the years and the amount of consumption of some drugs (alcohol, methamphetamine, and tobacco) with cytotoxicity markers such as KL, KX, and PNs.
- 1 January 2024
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 65 (1-2) , 84-95
Cytogenotoxicity effects in addicts with multidrug consumption
Drug abuse is considered a global health problem with serious social impact. In recent decades, changes in drug consumption patterns have shown a clear rising trend in the use of multiple drugs. Although the buccal micronucleus cytome (BMCyt) assay has evaluated cytotoxicity in drug abuse, there has not been an approach that takes into account this pattern of multiple drug use. Therefore, in this study, we evaluate for the first time the cytogenotoxic effects in multidrug users, and its correlation with the amount consumed and years of abuse. This study was conducted on 166 individuals by the BMCyt assay. A total of 83 individuals with a history of multiple licit (alcohol and tobacco) and at least one illicit drug abuse (marijuana, methamphetamines, cocaine, and/or inhalants), and 83 healthy individuals, non‐drug abusers were analyzed. The results showed that drug abusers had higher frequencies of nuclear abnormalities nuclear buds, binucleated cells, pyknotic nuclei (PNs), karyorrhexis (KX), and abnormally condensed chromatin when compared with healthy controls. Moreover, results suggests that the use of licit and illicit drugs is related to cytogenotoxic damage, as was shown by an upward trend in the frequency of nuclear abnormalities identified in groups 1 (alcohol + tobacco + at least one illicit drug) and 2 (tobacco + at least one illicit drug). Furthermore, a positive correlation was found in the different groups, between the years and the amount of consumption of some drugs (alcohol, methamphetamine, and tobacco) with cytotoxicity markers such as KL, KX, and PNs.
- Open Access
- 30 October 2023
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 45 (11) , 8716-8732
mtDNA Single-Nucleotide Variants Associated with Type 2 Diabetes
Type 2 diabetes (T2D) is a chronic systemic disease with a complex etiology, characterized by insulin resistance and mitochondrial dysfunction in various cell tissues. To explore this relationship, we conducted a secondary analysis of complete mtDNA sequences from 1261 T2D patients and 1105 control individuals. Our findings revealed significant associations between certain single-nucleotide polymorphisms (SNPs) and T2D. Notably, the variants m.1438A>G (rs2001030) (controls: 32 [27.6%], T2D: 84 [72.4%]; OR: 2.46; 95%CI: 1.64–3.78; p < 0.001), m.14766C>T (rs193302980) (controls: 498 [36.9%], T2D: 853 [63.1%]; OR: 2.57, 95%CI: 2.18–3.04, p < 0.001), and m.16519T>C (rs3937033) (controls: 363 [43.4%], T2D: 474 [56.6%]; OR: 1.24, 95%CI: 1.05–1.47, p = 0.012) were significantly associated with the likelihood of developing diabetes. The variant m.16189T>C (rs28693675), which has been previously documented in several studies across diverse populations, showed no association with T2D in our analysis (controls: 148 [13.39] T2D: 171 [13.56%]; OR: 1.03; 95%CI: 0.815–1.31; p = 0.83). These results provide evidence suggesting a link between specific mtDNA polymorphisms and T2D, possibly related to association rules, topological patterns, and three-dimensional conformations associated with regions where changes occur, rather than specific point mutations in the sequence.
- 30 October 2023
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 45 (11) , 8716-8732
Open AccessmtDNA Single-Nucleotide Variants Associated with Type 2 Diabetes
Type 2 diabetes (T2D) is a chronic systemic disease with a complex etiology, characterized by insulin resistance and mitochondrial dysfunction in various cell tissues. To explore this relationship, we conducted a secondary analysis of complete mtDNA sequences from 1261 T2D patients and 1105 control individuals. Our findings revealed significant associations between certain single-nucleotide polymorphisms (SNPs) and T2D. Notably, the variants m.1438A>G (rs2001030) (controls: 32 [27.6%], T2D: 84 [72.4%]; OR: 2.46; 95%CI: 1.64–3.78; p < 0.001), m.14766C>T (rs193302980) (controls: 498 [36.9%], T2D: 853 [63.1%]; OR: 2.57, 95%CI: 2.18–3.04, p < 0.001), and m.16519T>C (rs3937033) (controls: 363 [43.4%], T2D: 474 [56.6%]; OR: 1.24, 95%CI: 1.05–1.47, p = 0.012) were significantly associated with the likelihood of developing diabetes. The variant m.16189T>C (rs28693675), which has been previously documented in several studies across diverse populations, showed no association with T2D in our analysis (controls: 148 [13.39] T2D: 171 [13.56%]; OR: 1.03; 95%CI: 0.815–1.31; p = 0.83). These results provide evidence suggesting a link between specific mtDNA polymorphisms and T2D, possibly related to association rules, topological patterns, and three-dimensional conformations associated with regions where changes occur, rather than specific point mutations in the sequence.